CIK: 0000310158 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 13, 2025
Total Value ($000): $215,600 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PSNL | PERSONALIS INC | 14,044,943 | $92,135 | 42.7% | $4.62 | +0.6% | COM | 71535D106 |
| MRNA | MODERNA INC | 2,308,190 | $63,683 | 29.5% | $47.80 | -44.9% | COM | 60770K107 |
| KYMR | KYMERA THERAPEUTICS INC | 772,165 | $33,697 | 15.6% | $45.17 | -23.8% | COM | 501575104 |
| — | ENTRADA THERAPEUTICS INC | 1,739,768 | $11,691 | 5.4% | $17.29 | — | COM | 29384C908 |
| ALEC | ALECTOR INC | 3,545,719 | $4,964 | 2.3% | $3.76 | -66.7% | COM | 014442107 |
| — | EVAXION BIOTECH A/S | 1,214,126 | $2,975 | 1.4% | $1.40 | — | SPONSORED ADS | 29970R204 |
| — | SUTRO BIOPHARMA INC | 2,723,509 | $1,944 | 0.9% | $1.84 | — | COM | 869367102 |
| — | LAVA THERAPEUTICS NV | 1,149,345 | $1,517 | 0.7% | $0.95 | — | SHS | N51517105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 93,414 | $1,306 | 0.6% | $21.74 | -37.6% | COM | 92790C104 |
| XLO | XILIO THERAPEUTICS INC | 1,483,758 | $1,009 | 0.5% | $0.98 | -23.2% | COM | 98422T100 |
| CARM | CARISMA THERAPEUTICS INC | 1,473,240 | $577 | 0.3% | $0.82 | -67.5% | COM | 14216R101 |
| NEUP | NEUPHORIA THERAPEUTICS INC | 10,027 | $71 | 0.0% | $3.53 | +64.3% | COM | 64136E102 |
| HURA | TUHURA BIOSCIENCES | 13,950 | $31 | 0.0% | $3.38 | 0.0% | COM | 898920103 |